Drugmakers close plants in face of Hurricane Sandy

Like most manufacturers, drugmakers along the East Coast of the U.S. shut down plants Monday ahead of Hurricane Sandy's landfall. No disruptions of supplies of drugs to patients were reported from the closures.

Some companies were planning to keep facilities shut today as the worst of the storm blows through, although some were evaluating whether to run night shifts, according to the Associated Press. Plants and offices at Johnson & Johnson ($JNJ) and GlaxoSmithKline ($GSK) operations in the Northeast were among those closed. Also closing plants were AstraZeneca ($AZN), Daiichi Sankyo, Teva Pharmaceutical Industries ($TEVA) and Novartis ($NVS).

The storm led the New York Stock Exchange (NYSE) to remain closed Tuesday and for several companies to delay earnings reports. Pfizer ($PFE) and Vertex Pharmaceuticals ($VRTX), both moved earnings reports to Thursday. Story | More

 

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.